Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27141819 | 1.00 | DPP7 (0.33) | DPP7 | |
| SCHEMBL15542441 | 1.00 | DPP7 (0.33) | DPP7 | |
| SCHEMBL5965075 | 1.00 | — | — | |
| SCHEMBL27142083 | 1.00 | DPP7 (0.33) | DPP7 | |
| SCHEMBL27141559 | 1.00 | DPP7 (0.33) | DPP7 | |
| SCHEMBL1791308 | 0.97 | — | — | |
| SCHEMBL9253590 | 0.90 | — | — | |
| SCHEMBL93547 | 0.83 | — | — | |
| Butadiene SCHEMBL9711293 | 0.80 | — | — | |
| SCHEMBL1132984 | 0.79 | DPP7 (0.39) | DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815413-B2 | SATURATED OR UNSATURATED CYCLOHEXADECANONES ARE GRAND FRAGRANCES WITH MUSCONE NOTE WITH WHICH PERFUMES WITH NEW ODOR NOTES CAN BE PREPARED | SYMRISE GMBH & CO. KG (DE) | 2004-11-09 | — | — | US | disclosed |
| US-20020055453-A1 | Novel macrocyclic ketones | SYMRISE GMBH & CO. KG (DE) | 2002-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055453-A1 | Novel macrocyclic ketones | FASN, KCNK5, NOTUM | DPP7 3921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.